David Radzik

1.7k total citations
19 papers, 1.1k citations indexed

About

David Radzik is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Economics and Econometrics. According to data from OpenAlex, David Radzik has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 2 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Economics and Econometrics. Recurrent topics in David Radzik's work include Cardiac Arrhythmias and Treatments (12 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Atrial Fibrillation Management and Outcomes (9 papers). David Radzik is often cited by papers focused on Cardiac Arrhythmias and Treatments (12 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Atrial Fibrillation Management and Outcomes (9 papers). David Radzik collaborates with scholars based in France, Canada and United States. David Radzik's co-authors include Stuart J. Connolly, Stefan H. Hohnloser, Jean‐Marc Davy, Harry J.G.M. Crijns, Etienne Aliot, Alessandro Capucci, Denis‐Claude Roy, Bramah N. Singh, Peter R. Kowey and Gaetano Maria De Ferrari and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

David Radzik

19 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Radzik France 9 932 139 92 85 59 19 1.1k
D G Julian United Kingdom 10 902 1.0× 90 0.6× 37 0.4× 95 1.1× 109 1.8× 27 1.1k
Joon‐Han Shin South Korea 15 642 0.7× 307 2.2× 67 0.7× 70 0.8× 88 1.5× 80 857
A. J. M. Timmermans Netherlands 6 1.7k 1.8× 89 0.6× 50 0.5× 27 0.3× 25 0.4× 7 1.8k
Adam E. Schussheim United States 10 354 0.4× 249 1.8× 37 0.4× 22 0.3× 51 0.9× 14 549
Irene Savelieva United Kingdom 13 1.5k 1.6× 165 1.2× 101 1.1× 36 0.4× 76 1.3× 15 1.6k
Wei-Kung Tseng Taiwan 13 227 0.2× 62 0.4× 56 0.6× 34 0.4× 62 1.1× 20 442
Yu. M. Lopatin Russia 14 518 0.6× 54 0.4× 58 0.6× 54 0.6× 54 0.9× 59 643
Antonios Sideris Greece 18 946 1.0× 49 0.4× 31 0.3× 25 0.3× 214 3.6× 81 1.1k
Michael Fisher United Kingdom 12 211 0.2× 104 0.7× 30 0.3× 22 0.3× 54 0.9× 23 382
Kyoo-Rok Han South Korea 9 259 0.3× 122 0.9× 39 0.4× 37 0.4× 15 0.3× 19 383

Countries citing papers authored by David Radzik

Since Specialization
Citations

This map shows the geographic impact of David Radzik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Radzik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Radzik more than expected).

Fields of papers citing papers by David Radzik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Radzik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Radzik. The network helps show where David Radzik may publish in the future.

Co-authorship network of co-authors of David Radzik

This figure shows the co-authorship network connecting the top 25 collaborators of David Radzik. A scholar is included among the top collaborators of David Radzik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Radzik. David Radzik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Hohnloser, Stefan H., Stuart J. Connolly, A. John Camm, Jonathan L. Halperin, & David Radzik. (2014). An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation. EP Europace. 16(8). 1117–1124. 8 indexed citations
3.
Guerra, Federico, Stefan H. Hohnloser, Peter R. Kowey, et al.. (2014). Efficacy and Safety of Dronedarone in Patients Previously Treated With Other Antiarrhythmic Agents. Clinical Cardiology. 37(12). 717–724. 8 indexed citations
4.
Hohnloser, Stefan H., Jonathan L. Halperin, A. John Camm, et al.. (2014). Interaction Between Digoxin and Dronedarone in the PALLAS Trial. Circulation Arrhythmia and Electrophysiology. 7(6). 1019–1025. 47 indexed citations
5.
Connolly, Stuart J., Harry J.G.M. Crijns, Denis Roy, et al.. (2013). Effects of Dronedarone Started Rapidly After Amiodarone Discontinuation. Clinical Cardiology. 36(2). 88–95. 6 indexed citations
7.
Aliot, Etienne, Alessandro Capucci, Stuart J. Connolly, et al.. (2011). Celivarone for Maintenance of Sinus Rhythm and Conversion of Atrial Fibrillation/Flutter. Journal of Cardiovascular Electrophysiology. 23(5). 462–472. 8 indexed citations
8.
9.
Heuzey, Jean‐Yves Le, Gaetano Maria De Ferrari, David Radzik, et al.. (2010). A Short‐Term, Randomized, Double‐Blind, Parallel‐Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study. Journal of Cardiovascular Electrophysiology. 21(6). 597–605. 233 indexed citations
10.
Levine, T. Barry, Thomas D. Giles, David Radzik, & Jalal K. Ghali. (2010). Effect of Dronedarone on Exercise Capacity and Cardiac Function in Patients With Severe Left Ventricular Dysfunction and Compensated Stable Heart Failure. Cardiovascular Drugs and Therapy. 24(5-6). 449–458. 3 indexed citations
11.
Kowey, Peter R., Bramah N. Singh, Stuart J. Connolly, et al.. (2010). IMPACT OF DRONEDARONE STARTED RAPIDLY AFTER AMIODARONE DISCONTINUATION. Journal of the American College of Cardiology. 55(10). A1.E3–A1.E3. 1 indexed citations
13.
Singh, Bramah N., Stuart J. Connolly, Harry J.G.M. Crijns, et al.. (2007). Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter. New England Journal of Medicine. 357(10). 987–999. 433 indexed citations
14.
Wadhani, Nitin, Jonnalagedda S.M. Sarma, Bramah N. Singh, David Radzik, & Christine Gaud. (2006). Dose-Dependent Effects of Oral Dronedarone on the Circadian Variation of RR and QT Intervals in Healthy Subjects: Implications for Antiarrhythmic Actions. Journal of Cardiovascular Pharmacology and Therapeutics. 11(3). 184–190. 9 indexed citations
15.
Trimarco, Bruno, et al.. (1995). Efficacy and safety of the 200–300 mg sustained release formulation of diltiazem administered once daily in patients with stable angina. European Journal of Clinical Pharmacology. 47(6). 493–496. 3 indexed citations
16.
Lemery, Robert, Mario Talajic, Denis‐Claude Roy, et al.. (1994). Catheter ablation using radiofrequency or low-energy direct current in pediatric patients with the Wolff-Parkinson-White syndrome. The American Journal of Cardiology. 73(2). 191–194. 6 indexed citations
17.
Radzik, David, Nicolaas H. van Doesburg, & A Davignon. (1994). Reply. Journal of the American College of Cardiology. 23(3). 829–830. 1 indexed citations
18.
Radzik, David, et al.. (1993). Predictive factors for spontaneous closure of atrial septal defects diagnosed in the first 3 months of life. Journal of the American College of Cardiology. 22(3). 851–853. 88 indexed citations
19.
Lemery, Robert, Mario Talajic, Denis Roy, et al.. (1993). Results of a comparative study of low energy direct current with radiofrequency ablation in patients with the Wolff-Parkinson-White syndrome.. Heart. 70(6). 580–584. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026